Related Experiment Video
Updated: Nov 24, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Multipodal insulin mimetics built on adamantane or proline scaffolds
Jan Hajduch1, Benjamin Fabre1, Benjamin Klopp1
1The Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo n. 2, 16610 Praha 6, Czech Republic.
Adamantane scaffolds effectively mimic insulin, binding strongly to the insulin receptor. Proline scaffolds showed weaker binding, suggesting scaffold structure and peptide flexibility are key for designing effective peptide hormone mimetics.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Biophysics
Background:
- Multi-orthogonal molecular scaffolds serve as foundational structures for bioactive compounds.
- Designing effective peptide hormone mimetics requires careful consideration of scaffold and peptide modifications.
Purpose of the Study:
- To synthesize and evaluate adamantane and proline-based scaffolds for creating insulin mimetics.
- To investigate the impact of scaffold structure and peptide flexibility on insulin receptor binding affinity.
Main Methods:
- Solid-phase synthesis of four tri-orthogonal scaffolds (adamantane or proline-based).
- Preparation of model insulin mimetics with two distinct peptides attached to the scaffolds.
- Binding affinity assays to determine dissociation constants (Kd) for insulin receptor interaction.
- Molecular dynamics simulations and molecular modeling to elucidate binding modes and flexibility effects.
Main Results:
- Adamantane-derived insulin mimetics demonstrated superior binding affinity (Kd = 0.5 μM) compared to proline-derived mimetics (Kd = 15-38 μM).
- Molecular dynamics simulations indicated that flexible spacers enhance binding affinity by increasing conformational adaptability.
- Molecular modeling provided insights into potential binding interactions with the insulin receptor.
Conclusions:
- The central scaffold's structure significantly influences the binding efficacy of peptide hormone mimetics.
- Peptide flexibility, modulated by spacers, plays a crucial role in achieving high binding affinity to the insulin receptor.
- Diverse scaffold designs should be explored for optimizing the development of novel peptide hormone mimetics.
More Related Videos
11:09Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
Published on: August 1, 2018
09:33Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
Published on: June 2, 2018
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Oral Hypoglycemic Agents: Glinides
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Dipeptidyl Peptidase 4 Inhibitors
Insulin: The Receptor and Signaling Pathways